Genmab A/S Sponsored ADR (GMAB) at a glance

Genmab A/S Sponsored ADR (GMAB) is a large-cap Healthcare company. It trades at $32.51, with a P/E of 19.1, a 21% profit margin and revenue growth of 25.3%. It does not pay a dividend. Vestovix scores it 59/100 overall. Its strongest dimension is Value (81/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$32.51

Market cap

$15.40B

P/E ratio

19.1

Dividend yield

None

Beta

0.68

52-week range

$23.62 to $35.43